Table 4. Association of ETS-1 polymorphisms with clinical characteristics in RA patients.

SNPs	Model	Genotype	DAS28		RF(IU/L)		CRP(mg/L)		Anti-CCP(U/L)
			Md±IQR	P Value	Md±IQR	P Value	Md±IQR	P Value	Md±IQR	P Value
rs73013527		CC	6.50±1.53		344.00±1527.45		11.05±38.67		307.15±398.05
		CT	6.62±2.21	0.001	323.00±1123.8	0.821	18.70±55.53	0.028	371.40±257.45	0.351
		TT	7.81±1.01		465.00±939.5		49.5±42.68		369.80±235.82
	Dominant	CC	6.50±1.53		344.00±1527.45		11.05±38.67		307.15±398.05
		CT+TT	6.80±1.84	0.162	366.00±1077.80	0.952	21.60±57.72	0.022	371.40±249.90	0.15
	Recessive	TT	7.81±1.01		465.00±939.5		49.5±42.68		369.80±235.82
		CC+CT	6.54±1.62	<0.001	342.00±1140.45	0.572	15.60±41.99	0.034	351.10±382.70	0.509
rs4937333		CC	6.67±1.69		342.00±1535.25		16.10±49.36		328.60±403.54
		CT	6.52±1.98	0.127	310.00±923.55	0.313	18.50±44.75	0.983	363.40±376.00	0.777
		TT	6.71±1.66		635.00±1407.5		10.7±55.9		350.10±220.5
	Dominant	CC	6.67±1.69		342.00±1535.25		16.10±49.36		328.60±403.54
		CT+TT	6.58±1.65	0.354	410.00±986.62	0.592	17.05±44.21	0.859	361.65±327.32	0.585
	Recessive	TT	6.71±1.66		635.00±1407.5		10.7±55.9		350.10±220.5
		CC+CT	6.56±1.70	0.134	329.00±1129.12	0.216	17.65±46.32	0.926	361.65±383.3	0.559
rs11221332		CC	6.60±1.65		342.00±1188.85		16.7±47.32		340.10±379.7
		CT	6.73±1.37	0.423	431.00±1015.2	0.874	17.20±48.73	0.860	416.65±242.5	0.262
	Dominant	CC	6.60±1.65		342.00±1188.85		16.7±47.32		340.10±379.7
		CT+TT	6.73±1.37	0.423	431.00±1015.2	0.874	17.20±48.73	0.860	416.65±242.5	0.262

Abbreviation: Md±IQR: median±quartile interval.

Note: Significant p-values (<0.05) are highlighted in bold.